DRREDDYUpdated 31 Aug 2026, 22:30

Dr. Reddy S Laboratories

DRREDDYUpdated 31 Aug 2026, 22:30

Market Cap

₹96,372Cr.

Current Price

₹1,154

High / Low

₹1,415/1,080

Stock P/E

145

ROE10.2%

ROCE12.1%

Book Value₹376

Face Value₹1.00

Dividend Yield0.69%

About

Dr. Reddy's Laboratories Ltd is a leading India-based pharmaceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical services (CPS), generics, biosimilars and differentiated formulations.

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	172	138	165	164	128	143	112	125	92	87	94	73
Inventory Days	223	234	256	258	242	224	250	242	219	291	275	268
Days Payable	93	99	110	147	124	109	118	121	127	148	120	103
Cash Conversion Cycle	302	273	311	274	246	257	243	247	184	230	250	239
Working Capital Days	99	82	112	98	125	116	95	89	95	130	63	39
ROCE %	16%	12%	11%	5%	12%	19%	15%	12%	19%	25%	26%	12%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 31 August 2026 at 22:30

DR. REDDY S LABORATORIES (DRREDDY) financials — quarterly results, P&L, cash flow, balance sheet, shareholding